These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 38315283)
21. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho. Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219 [TBL] [Abstract][Full Text] [Related]
22. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer. Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866 [TBL] [Abstract][Full Text] [Related]
23. Wang Q; Guo M; Liu Y; Xu M; Shi L; Li X; Zhao J; Zhang H; Wang G; Chen W Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334879 [TBL] [Abstract][Full Text] [Related]
24. Modified Lichong decoction intervenes in colorectal cancer by modulating the intestinal flora and the Wnt/β-catenin signaling pathway. Liu L; Zhao M; Lang X; Jia S; Kang X; Liu Y; Liu J J Cancer Res Clin Oncol; 2024 May; 150(5):234. PubMed ID: 38710918 [TBL] [Abstract][Full Text] [Related]
25. Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3. Luo T; Guo Z; Liu D; Guo Z; Wu Q; Li Q; Lin R; Chen P; Ou C; Chen M Gut Microbes; 2022; 14(1):2077602. PubMed ID: 35613310 [TBL] [Abstract][Full Text] [Related]
26. Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway. Li C; Zhou W; Li M; Shu X; Zhang L; Ji G Biomed Pharmacother; 2021 Jul; 139():111587. PubMed ID: 33865013 [TBL] [Abstract][Full Text] [Related]
27. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice. Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675 [TBL] [Abstract][Full Text] [Related]
28. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis. Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q Front Immunol; 2020; 11():588079. PubMed ID: 33072135 [TBL] [Abstract][Full Text] [Related]
29. Targeting the Gut-Kidney Axis in Diarrhea with Kidney-Yang Deficiency Syndrome: The Role of Sishen Pills in Regulating TMAO-Mediated Inflammatory Response. Xie S; Fang L; Deng N; Shen J; Tan Z; Peng X Med Sci Monit; 2024 Jun; 30():e944185. PubMed ID: 38898640 [TBL] [Abstract][Full Text] [Related]
30. Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack. Yin J; Liao SX; He Y; Wang S; Xia GH; Liu FT; Zhu JJ; You C; Chen Q; Zhou L; Pan SY; Zhou HW J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26597155 [TBL] [Abstract][Full Text] [Related]
31. Kaempferol acts on bile acid signaling and gut microbiota to attenuate the tumor burden in ApcMin/+ mice. Li X; Khan I; Huang G; Lu Y; Wang L; Liu Y; Lu L; Hsiao WLW; Liu Z Eur J Pharmacol; 2022 Mar; 918():174773. PubMed ID: 35065044 [TBL] [Abstract][Full Text] [Related]
32. Trimethylamine N-oxide ameliorates hepatic damage including reduction of hepatic bile acids and cholesterol in Miyata M; Takeda K; Nagira S; Sugiura Y Int J Food Sci Nutr; 2024 Jun; 75(4):385-395. PubMed ID: 38690724 [TBL] [Abstract][Full Text] [Related]
33. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer. Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532 [TBL] [Abstract][Full Text] [Related]
34. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH. Hernandez GV; Smith VA; Melnyk M; Burd MA; Sprayberry KA; Edwards MS; Peterson DG; Bennet DC; Fanter RK; Columbus DA; Steibel JP; Glanz H; Immoos C; Rice MS; Santiago-Rodriguez TM; Blank J; VanderKelen JJ; Kitts CL; Piccolo BD; La Frano MR; Burrin DG; Maj M; Manjarin R Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G582-G609. PubMed ID: 32003601 [TBL] [Abstract][Full Text] [Related]
35. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury. Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034 [TBL] [Abstract][Full Text] [Related]
36. Synbindin deficiency inhibits colon carcinogenesis by attenuating Wnt cascade and balancing gut microbiome. Ai L; Ren Y; Li Y; Chen H; Qian Y; Lu S; Xu A; Ren L; Zhao S; Chen Z; Chen YX; Xu J; Fang JY Int J Cancer; 2019 Jul; 145(1):206-220. PubMed ID: 30561033 [TBL] [Abstract][Full Text] [Related]
37. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. Romano KA; Vivas EI; Amador-Noguez D; Rey FE mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704 [TBL] [Abstract][Full Text] [Related]
38. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure. Organ CL; Li Z; Sharp TE; Polhemus DJ; Gupta N; Goodchild TT; Tang WHW; Hazen SL; Lefer DJ J Am Heart Assoc; 2020 May; 9(10):e016223. PubMed ID: 32390485 [TBL] [Abstract][Full Text] [Related]
39. Trimethylamine N-Oxide Promotes Cell Proliferation and Angiogenesis in Colorectal Cancer. Yang S; Dai H; Lu Y; Li R; Gao C; Pan S J Immunol Res; 2022; 2022():7043856. PubMed ID: 35832644 [No Abstract] [Full Text] [Related]
40. Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor. Smith DL; Keshavan P; Avissar U; Ahmed K; Zucker SD Carcinogenesis; 2010 Jun; 31(6):1100-9. PubMed ID: 20194350 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]